PROLLENIUM announced the launch of VAMP Advanced — a breakthrough skin rejuvenation treatment that helps improve skin tonicity, tighten pores and smooth wrinkles to restore skin’s glow, hydration and texture.

VAMP Advanced is a patent-pending, proprietary topical sterile bio-revitalizing solution. The formula is an enhanced upgrade of their previous VAMP line, formulated with a potent blend of 5x more medical-grade high purity PDRN, along with vitamins, amino acids, minerals and hyaluronic acid.

PDRN are fragments of low molecular weight DNA extracted from wild salmon and purified to over 95% to ensure safety, stability, and biocompatibility. Compared to other salmon DNA extracts such as Polynucleotide (PN) and hydrolyzed DNA, PDRN demonstrates clinically proven skin rejuvenation benefits beyond structural support or surface hydration.

“When evaluating PDRN-based products, I focus on quality and manufacturing standards—including purity and formulation consistency. Evidence suggests that PDRN’s rejuvenating effects are distinct from other DNA derivatives. VAMP Advanced contains five times more PDRN than the original formulation, and it’s manufactured in Canada using medical-grade ingredients sterilized for clinical use. For health care professionals focusing on supporting skin quality and radiance, the science behind PDRN and the formulation standards behind VAMP Advanced make it a differentiated option in this category.” said Dr. Katie Beleznay, MD, FRCPC, Dermatologist, Vancouver, BC.

As 78% of consumers are concerned about skin texture and discoloration, and 86% of aesthetics patients are leaning toward treatments that stimulate natural bodily processes, PROLLENIUM is committed to empowering aesthetic providers with high-efficacy solutions rooted in skin science. VAMP Advanced is intended for topical use, and clinical studies indicate its key ingredient, PDRN, can be used to enhance skin quality and reduce visible signs of aging.

SOURCEMedEsthetics
Previous articleLynton Lasers unveils ONDA Pro
Next articleMedytox to launch cholic acid-based fat reduction injection Nuviju